Fed fines Deutsche Bank $186M over historic sanctions, AML lapses
By 
Kyle Brasseur2023-07-19T20:45:00
The Federal Reserve Board fined Deutsche Bank $186 million regarding violations of previous consent orders addressing alleged sanctions and anti-money laundering (AML) weaknesses and control failures relating to the bank’s relationship with Danske Bank’s Estonia branch.
The penalty, levied against Deutsche Bank, its New York branch, and other of its U.S. affiliates, is comprised of two parts. Deutsche Bank was fined more than $140 million regarding its alleged violations of the sanctions and AML orders and $46.2 million regarding its relationship with Danske Estonia, the Fed detailed in a consent order published Wednesday.
The Fed also announced a separate written agreement with Deutsche Bank, in which the bank consented to submit plans to enhance its governance, risk management, and controls.
Related articles
-
News BriefReport: Morgan Stanley AML controls draw Fed scrutiny
The wealth management arm of Morgan Stanley is being probed by the Federal Reserve regarding the controls it has in place to prevent wealthy foreign customers from laundering money, according to a report from the Wall Street Journal.
-
News BriefDeutsche Bank unit fined $25M in ESG, AML settlements
DWS Investment Management Americas agreed to pay $25 million in penalties across separate settlements with the Securities and Exchange Commission addressing alleged misstatements in environmental, social, and governance investments and anti-money laundering violations.
-
News BriefTD Bank expecting punishment in BSA/AML probes
TD Bank disclosed in a shareholder report it is facing regulatory investigations regarding its Bank Secrecy Act/anti-money laundering compliance program.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”